A soaring price, a silent fight: Thioguanine portends new access barriers to life‐saving treatments for children with cancer
Open Access
- 27 October 2024
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (1) , e31410
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Geographic Access to Pediatric Cancer Care in the USJAMA Network Open, 2023
- Barriers in access to oncology drugs — a global crisisNature Reviews Clinical Oncology, 2022
- Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of LiteratureFrontiers in Public Health, 2021
- Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trialBlood, 2010
- Therapy of low‐risk subsets of childhood acute lymphoblastic leukemia: When do we say enough?Pediatric Blood & Cancer, 2005